Loading company…
Synchron, Inc., based in Brooklyn, develops the Chiral brain-computer interface, which is placed through an endovascular procedure.
Founded in 2016 and headquartered in Brooklyn, US, Synchron, Inc. develops the Chiral brain-computer interface, which lets users control digital devices by thought and is placed through a minimally invasive endovascular procedure. The device is positioned as investigational, and the company is working on clinical trials and preparing for a commercial launch. In November 2025, Synchron raised USD 200 million in a Series D round led by Double Point Ventures, with participation from a group of other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in